- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on BCG
Total 1117 results
-
Polish Adult Leukemia GroupCompletedChronic Myeloid Leukemia
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical CenterCompleted
-
Grigore T. Popa University of Medicine and PharmacyCardiovascular Diseases Institute IASI, RomaniaUnknownOxidative Stress | STEMI | Left Ventricular Dysfunction | Oxidative Stress Induction | Primary PCI | hFABP | BCMRomania
-
Ariad PharmaceuticalsCompletedChronic Myelogenous Leukemia | Hematologic MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia in Chronic PhaseUnited States
-
Kanto CML Study GroupUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Myelogenous Leukemia, Chronic, Chronic PhaseJapan
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaJapan
-
University of Southern CaliforniaNational Cancer Institute (NCI); Vasgene Therapeutics, Inc; Whittier FoundationTerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Philadelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Recurrent Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Plasma Cell Myeloma | Myeloproliferative Neoplasm | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia and other conditionsCanada
-
Medical Enterprises Ltd.TerminatedUrinary Bladder Cancer | Bladder Cancer | Malignant Tumor of Urinary Bladder | Bladder Neoplasm | Cancer of Bladder | Carcinoma in Situ of Bladder | Bladder Tumors | Cancer of the Bladder | Neoplasms, Bladder | Papillary Carcinoma of Bladder (Diagnosis) | BCG-Unresponsive Bladder CancerUnited States
-
Shenzhen TargetRx, Inc.M.D. Anderson Cancer CenterRecruitingChronic Myelogenous LeukemiaUnited States
-
Poitiers University HospitalRecruitingChronic Myeloid Leukemia | Tyrosine Kinase InhibitorsFrance
-
Grupo Cooperativo de Hemopatías MalignasRecruitingChronic Myeloid Leukaemia Recurrent | Chronic Myeloid Leukemia, in RelapseMexico
-
Nanfang Hospital of Southern Medical UniversityRecruitingValidity and SafetyChina
-
National Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States
-
Jonsson Comprehensive Cancer CenterBristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterNovartisCompletedLeukemia, Myelogenous, ChronicUnited States
-
Emory UniversityTerminatedLeukemia | Chronic Myeloid Leukemia | Chronic Myelogenous LeukemiaUnited States
-
The University of Hong KongUnknownCessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous LeukaemiaLeukemia, Myelogenous, Chronic PhaseHong Kong
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, AcuteUnited States, France, Canada
-
M.D. Anderson Cancer CenterBreakThrough TherapeuticsCompletedChronic Myeloid Leukemia | Minimal Residual DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsRecruitingChronic Myeloid LeukemiaUnited States
-
Novartis PharmaceuticalsRecruiting
-
FundaleuRecruiting
-
Hikma Pharmaceuticals LLCRecruiting
-
Novartis PharmaceuticalsRecruitingLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Chronic Myelogenous LeukemiaDenmark, Spain, France, Germany, Lebanon, Italy, Argentina, Czechia, Portugal, United Kingdom, Brazil, Mexico, Taiwan, Austria, Canada, Korea, Republic of, Russian Federation, Turkey, United States, Singapore, Japan, Bulgaria, Poland, Romani... and more
-
Poitiers University HospitalUniversity Medical Center Groningen; Imperial College London; University of Liege and other collaboratorsRecruitingChronic Myeloid LeukemiaDenmark, China, Germany, Australia, Belgium, Brazil, Chile, Croatia, Czechia, France, Greece, Japan, Lebanon, Poland, Spain, Turkey, Austria, Belarus, Netherlands, Slovakia
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New ZealandActive, not recruiting
-
Incyte BioSciences FranceCompletedChronic Myeloid LeukemiaFrance
-
Novartis PharmaceuticalsCompletedPhiladelphia Positive (Ph+) Chronic Myelogenous LeukemiaUnited States, France, Korea, Republic of, Thailand, Italy, Netherlands, Turkey, Hungary, Russian Federation, Spain, United Kingdom, Japan, Malaysia
-
University Hospital, AngersCompletedSolid Tumor | Endothelial Dysfunction | Tumor Angiogenesis | CML (Chronic Myelogenous Leukemia)France
-
Prism Pharma Co., Ltd.inVentiv Health ClinicalCompletedAcute Myeloid Leukemia | Chronic Myeloid LeukemiaUnited States
-
Medical University of GrazCompletedChronic Myeloid LeukemiaAustria
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
University of ConnecticutCompletedStudy Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic PhaseLeukemia,Myeloid, Chronic | Leukemia,Myeloid,Philadelphia-PositiveUnited States
-
Peking University People's HospitalHenan Cancer Hospital; Wuhan Union Hospital, China; Zhejiang University; Peking... and other collaboratorsNot yet recruitingChronic Myeloid LeukemiaChina
-
University Hospital, Clermont-FerrandRecruiting
-
Assiut UniversityNot yet recruiting
-
Shenzhen TargetRx, Inc.Peking University People's HospitalRecruitingChronic Myelogenous LeukemiaChina
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaUnited States, United Kingdom, Hungary, Japan, Saudi Arabia, Australia, Germany, Canada, France, Netherlands, Spain, Lebanon, Turkey, Korea, Republic of, Argentina, Brazil, Bulgaria, Czechia, Israel, Italy, Mexico, Romania, Russian... and more
-
Northwestern UniversityNational Cancer Institute (NCI); Augusta University; Fondazione GIMEMA - Franco...Completed
-
PfizerCompleted
-
PfizerpH AssociatesCompletedChronic Myeloid LeukaemiaUnited Kingdom
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukaemiaUnited Kingdom
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, Chronic, Chronic-PhaseUnited States, Australia, France, Germany, Italy, Korea, Republic of, Sweden, Taiwan, Spain, Austria, Denmark, Belgium, Canada, Ireland, Switzerland, Netherlands, Peru, United Kingdom, South Africa, Argentina, Philippines, Singapore, Russian Federation and more